Safety of levonorgestrel 52 mg intrauterine system compared to copper intrauterine device: a population-based cohort study.
Sign Up to like & getrecommendations! Published in 2019 at "Contraception"
DOI: 10.1016/j.contraception.2019.02.011
Abstract: OBJECTIVE To compare the risk of all-cause death, hospitalizations (any cause), ectopic pregnancy, pelvic inflammatory disease or infection, uterine perforation, device removal, neuro-psychiatric drugs initiation, or new psychiatric visit(s) between levonorgestrel (LNG) 52 mg intrauterine… read more here.
Keywords: iud; copper; lng ius; intrauterine ... See more keywords
Safety and continued use of the levonorgestrel intrauterine system as compared with the copper intrauterine device among women living with HIV in South Africa: A randomized controlled trial
Sign Up to like & getrecommendations! Published in 2020 at "PLoS Medicine"
DOI: 10.1371/journal.pmed.1003110
Abstract: Background Women living with HIV (WLHIV) have lower rates of contraceptive use than noninfected peers, yet concerns regarding contraceptive efficacy and interaction with antiretroviral therapy (ART) complicate counseling. Hormonal contraceptives may increase genital tract HIV… read more here.
Keywords: non art; iud; hiv; lng ius ... See more keywords
Intrauterine Progestin Therapy as a New Approach to Premalignant Endometrial Polyps: A Prospective Observational Study
Sign Up to like & getrecommendations! Published in 2019 at "AntiCancer Research"
DOI: 10.21873/anticanres.13676
Abstract: Background/Aim: Endometrial hyperplastic polyps (EHP) may progress to endometrial carcinoma (EC) if left untreated. We aimed to prospectively investigate the efficacy of the low-dose levonorgestrel intrauterine system (LNG-IUS) as therapy for EHP with malignant potential.… read more here.
Keywords: risk; study; lng ius; intrauterine ... See more keywords